News | March 13, 2024
Nirma acquires majority stake in Glenmark Life Sciences
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
Pfizer to discuss regulatory submission with FDA, potentially leading to eighth indication for ADCETRIS
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
Vision loss due to Glaucoma can be prevented if it is detected and treated early
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
Subscribe To Our Newsletter & Stay Updated
